Adults with type 2 diabetes who initiate SGLT2 inhibitors within 3 months of a diagnosis of a urinary tract infection have a ...

Canagliflozin is generally well tolerated and improves blood sugar control in children and adolescents with type 2 diabetes, ...

In diabetes, newly released estimates said 26.5% of U.S. adults with a diagnosis had tried an injectable GLP-1 medication in 2024 -- up from 7.6% in 2018, according to the CDC's National Health ...

SGLT2 harvests sodium and glucose from the waste moving through the nephrons, and returns them to the blood. Blocking it with the inhibitors reduces blood sugar levels by forcing the sodium and ...

Germany: A retrospective cohort study has found that prior use of SGLT2 inhibitors in type 2 diabetes mellitus (T2DM) ...

A newer type of diabetes medication called sodium-glucose cotransporter-2 (SGLT2) inhibitors has been linked to a rare but ...

Children and adolescents with type 2 diabetes had greater reductions in HbA1c with an oral SGLT2 inhibitor compared with ...

However, nowadays, whether SGLT2 inhibition could reduce the risk of venous thrombosis is unclear. In light of this, a Mendelian randomization (MR) study was required to explore whether SGLT2 ...

Lastly, the comparison of SGLT2 inhibition vs. sulfonylurea featured 71,625 patients, of whom 60% were men, with a mean age of 59 years. Baseline characteristics were balanced across treatment groups.

With studies showing potential for SGLT2 inhibitors in heart failure, a study of HCP online conversations reveals cardiologists are still cautious. AstraZeneca had already been quick to consider ...